These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3369135)

  • 1. Efficacy of an immunoglobulin preparation from HIV carriers in preventing HIV replication in vitro.
    Tochikura TS; Nakashima H; Uemura Y; Goto T; Suyama T; Kobayashi N; Yamamoto N
    Vox Sang; 1988; 54(3):138-43. PubMed ID: 3369135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro.
    Tochikura TS; Nakashima H; Hirose K; Yamamoto N
    Biochem Biophys Res Commun; 1987 Oct; 148(2):726-33. PubMed ID: 2825669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 3'-azido-2',3'-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV)-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo.
    Nakashima H; Tochikura T; Kobayashi N; Matsuda A; Ueda T; Yamamoto N
    Virology; 1987 Jul; 159(1):169-73. PubMed ID: 3111083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
    Kannagi M; Kuroda MJ; Maeda Y; Harada S
    Microbiol Immunol; 1991; 35(9):729-40. PubMed ID: 1687290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of culture supernatant of MT-2 cells on human immunodeficiency virus-producing cells, MOLT-4/HIVHTLV-IIIB cells.
    Matsuyama T; Hamamoto Y; Yoshida T; Kido Y; Kobayashi S; Kobayashi N; Yamamoto N
    Jpn J Cancer Res; 1988 Feb; 79(2):156-9. PubMed ID: 3130348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-to-cell transmission of human immunodeficiency virus type 1 in the presence of azidothymidine and neutralizing antibody.
    Gupta P; Balachandran R; Ho M; Enrico A; Rinaldo C
    J Virol; 1989 May; 63(5):2361-5. PubMed ID: 2704079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
    Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
    AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location of human T-cell leukemia virus (HTLV) p19 antigen on virus-producing cells.
    Aoki T; Hamada C; Ohno S; Miyakoshi H; Koide H; Robert-Guroff M; Ting RC; Gallo RC
    Int J Cancer; 1984 Feb; 33(2):161-5. PubMed ID: 6319298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfation of polysaccharides generates potent and selective inhibitors of human immunodeficiency virus infection and replication in vitro.
    Nakashima H; Yoshida O; Tochikura TS; Yoshida T; Mimura T; Kido Y; Motoki Y; Kaneko Y; Uryu T; Yamamoto N
    Jpn J Cancer Res; 1987 Nov; 78(11):1164-8. PubMed ID: 2447045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human immunodeficiency virus type 1 (HIV-1) infection-enhancing factor in seropositive sera.
    Robinson WE; Montefiori DC; Mitchell WM
    Biochem Biophys Res Commun; 1987 Dec; 149(2):693-9. PubMed ID: 3426595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective killing of human immunodeficiency virus-infected and -producing cells by liposomes containing diphtheria toxin fragment A.
    Ikuta K; Ueda S; Uchida T; Okada Y; Kato S
    Jpn J Cancer Res; 1987 Nov; 78(11):1159-63. PubMed ID: 3121551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entry of human immunodeficiency virus (HIV) into MT-2, human T cell leukemia virus carrier cell line.
    Goto T; Harada S; Yamamoto N; Nakai M
    Arch Virol; 1988; 102(1-2):29-38. PubMed ID: 2904253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-I-carrying MT-4 cells persistently infected with HIV.
    Ikuta K; Morita C; Nakai M; Yamamoto N; Kato S
    Jpn J Cancer Res; 1988 Apr; 79(4):418-23. PubMed ID: 2898463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of human immunodeficiency virus antigens in infected cells by scanning/transmission-immunogold techniques.
    Herrera MI; Santa María I; de Andrés R; Nájera R
    Ultrastruct Pathol; 1988; 12(4):439-47. PubMed ID: 2844012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage.
    McGrath MS; Hwang KM; Caldwell SE; Gaston I; Luk KC; Wu P; Ng VL; Crowe S; Daniels J; Marsh J
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2844-8. PubMed ID: 2704750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus (HIV)-induced cell fusion: quantification and its application for the simple and rapid screening of anti-HIV substances in vitro.
    Tochikura TS; Nakashima H; Tanabe A; Yamamoto N
    Virology; 1988 Jun; 164(2):542-6. PubMed ID: 3369092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia.
    Tochikura TS; Nakashima H; Ohashi Y; Yamamoto N
    Med Microbiol Immunol; 1988; 177(5):235-44. PubMed ID: 3173237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
    Harada S; Koyanagi Y; Yamamoto N
    Virology; 1985 Oct; 146(2):272-81. PubMed ID: 2413616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression by neurotropin of production of human immuno-deficiency virus by the virus-producing MOLT-4 cell line.
    Imai H; Ikuta K; Ueda S; Suehiro S; Yamamoto N; Kato S
    Jpn J Cancer Res; 1987 Jul; 78(7):648-50. PubMed ID: 3114194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.